Psychedelic Policy & Law in 2022 By admin - February 21, 2023 50 Source RELATED ARTICLESMORE FROM AUTHOR Op-Ed: Iboga, Ibogaine & 5-MeO-DMT: What gets missed when complex medicines are reduced to standard protocols A Practitioner Statement on the Responsible Development of Ibogaine in the United States – Open Letter Dr. Michael Alpert and Peter Alberding – ALS, Existential Distress, and Ketamine Therapy
